Check latest subscription status, grey market premium (GMP), allotment date, listing date, and other key details here ...

Today is the last day for investors to subscribe for the Anthem Biosciences IPO, which so far has gathered a lot of attention ...

Anthem Biosciences is raising ₹3,395 crore through an initial share sale, which comprises of entirely an offer-for-sale by ...

The IPO attracted strong interest, receiving bids for 17.66 crore shares against 4.4 crore shares on offer. Non-institutional ...

The initial public offering of Anthem Biosciences Ltd. has been subscribed to nearly eight times the offer on its third and ...

Anthem Biosciences IPO closes today; check GMP, latest subscription stats, and key dates -act now before bidding ends!

Anthem Biosciences, ₹3,395 crore IPO was fully subscribed by Day 2, with strong interest from non-institutional investors, ...

Indian drugmaker Anthem Biosciences' ANTH.NS $395 million IPO was fully subscribed on the second day of bidding on Tuesday, ...

According to market observers, shares of the company are available at a premium of ₹101 in the grey market today ...

Anthem Biosciences Rs. 3,395 crore IPO fully subscribed on day 2 of offering on July 15: Our Bureau, Bengaluru Wednesday, July 16, 2025, 11:30 Hrs [IST] The initial public offerin ...

This IPO is entirely an offer for sale (OFS) of 5.96 crore equity shares by existing shareholders. The company itself will not receive any money from this offer. The price band has been set at Rs 570 ...

Among investor categories, Non-Institutional Investors (NIIs) have shown the highest interest, bidding 1.55 times their ...